All Industries

Top Oncology Companies

290 Oncology companies, sorted by total funding raised.

290

Companies

$17.1B

Combined Funding

Seed

Top Stage

Indexed tracks 290 Oncology companies that have collectively raised $17.1B in documented funding. The most-funded oncology companies tracked include BeiGene and Avenzo. Seed is the most common funding stage among oncology companies in this dataset.

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Arcus BiosciencesIPO

Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...

Hayward, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$544.0MJan 2024
Pathos

Pathos uses multimodal oncology data and AI to simulate clinical trials, identify responsive pati...

Chicago, United States51–200Artificial Intelligence, Biotech
Series DTotal funding$467.0MMay 2025
ImmunomedicsAcquired

Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...

Morris Plains, United States201–500Biotech, Oncology
Private EquityTotal funding$459.0MMay 2020
ArcellxAcquired

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...

Redwood City, United States51–200Biotech, Healthcare
SeedTotal funding$375.0MJan 2024
Oricell Therapeutics

Oricell develops next-generation cell therapies addressing unmet needs in oncology and immunology...

Shanghai, China51–200Oncology, Therapeutics
Venture RoundTotal funding$364.0MApr 2026
PIONYR ImmunotherapeuticsAcquired

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenviron...

South San Francisco, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$355.0MJun 2020
Bicara TherapeuticsIPO

Clinical-stage biopharma developing dual-action biologics that combine targeted therapy and immun...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$313.0MDec 2023
Flatiron HealthAcquired

Health technology company building oncology-specific electronic health record software and curati...

New York, United States501–1000Analytics, Healthcare
Series CTotal funding$313.0MJan 2016
CARGO Therapeutics

Clinical-stage biotech engineering best-in-class CAR T-cell therapies to overcome resistance to c...

San Carlos, United States51–200Biotech, Healthcare
Private EquityTotal funding$310.0MMay 2024
ArriVentIPO

Clinical-stage biopharma developing and commercializing oncology therapeutics, partnering to glob...

Newtown Square, United States11–50Biotech, Healthcare
Series BTotal funding$305.0MMar 2023
Concert AI

Provides AI and real-world oncology data solutions to life sciences companies, accelerating clini...

Boston, United States1001–5000Artificial Intelligence, Healthcare
Series CTotal funding$300.0MMar 2022
Harbinger Health

Harbinger Health develops biology- and AI-powered blood tests that help clinicians resolve uncert...

Cambridge, United States51–200Artificial Intelligence, Healthcare
Series CTotal funding$290.0MApr 2026
Nuvation Bio Inc.IPO

Global oncology company focused on developing therapies to tackle the toughest challenges in canc...

New York, United States51–200Biotech, Healthcare
Series ATotal funding$275.0MOct 2019
AbbiskoIPO

Abbisko Therapeutics discovers and develops differentiated small-molecule precision oncology and ...

Shanghai, China201–500Biotech, Oncology
Series DTotal funding$263.0MJan 2021
Elpi Science

Clinical-stage biopharmaceutical developing innovative immunotherapies for oncology and autoimmun...

ChinaBiotech, Oncology
Series CTotal funding$260.0MMay 2021
AntengeneIPO

Commercial-stage biopharmaceutical company developing first-in-class therapeutics for hematologic...

Shanghai, China201–500Biotech, Oncology
Series CTotal funding$238.0MJul 2020
Alterome TherapeuticsAcquired

Develops potentially safer, more precise therapies for aggressive cancers lacking effective optio...

San Diego, United States11–50Biotech, Genomics
Series BTotal funding$231.0MApr 2024
IO Biotech

Clinical-stage company developing immune-oncology therapeutics based on T-win technology

Copenhagen, United States51–200Biotech, Oncology
Venture RoundTotal funding$223.1MAug 2023
Radionetics

Precision oncology company developing radiopharmaceutical drug candidates

San Diego, United States11–50Biotech, Healthcare
Corporate RoundTotal funding$222.5MJul 2024
Atomwise

AI-native drug discovery company, now operating as Numerion Labs, that uses machine learning to e...

San Francisco, United States51–200Biotech, Artificial Intelligence
Series CTotal funding$213.0MMar 2024
Adicet Bio

Menlo Park, CA & Boston, MA

Redwood City, United States51–200Biotech, Healthcare
Venture RoundTotal funding$211.0MOct 2025
Galvanize Therapeutics

Redwood City medical device company developing Pulsed Electric Field systems, including the Aliya...

Redwood City, United States51–200Healthcare, Medical Devices
Series CTotal funding$210.0MSep 2025

Frequently Asked Questions

How many Oncology companies are tracked on Indexed?

Indexed tracks 290 Oncology companies, sorted by total funding raised.

How much funding have Oncology companies raised in total?

The Oncology companies tracked by Indexed have collectively raised $17.1B in documented funding.

What are the top-funded Oncology companies?

The most-funded Oncology companies tracked include BeiGene, Avenzo, Bicycle Therapeutics.

Who are the top investors in Oncology?

Leading investors active in Oncology include Pfizer Ventures, Novartis Venture Fund, Amgen.

Explore More

Other Industries